Panagora Asset Management Inc Revance Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$11.52 - $20.4 $565,896 - $1 Million
-49,123 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$12.36 - $20.31 $474,821 - $780,228
38,416 Added 358.79%
49,123 $958,000
Q4 2021

Feb 10, 2022
BUY
$12.46 - $27.87 $133,409 - $298,404
10,707 New
10,707 $175,000
Q2 2018

Aug 14, 2018
SELL
$27.45 - $33.35 $1.37 Million - $1.67 Million
-49,934 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$29.15 - $37.4 $1.46 Million - $1.87 Million
49,934 New
49,934 $1.54 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email